Clinical Trial: Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722182) titled 'Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC' on July 20.

Brief Summary: Background: Stereotactic body radiotherapy (SBRT) is a standard definitive local therapy for medically inoperable early stage non-small cell lung cancer (NSCLC). Navigation bronchoscopy guided microwave ablation is an emerging alternative that may reduce treatment burden and avoid ionising radiation. However, comparative evidence against SBRT remains limited.

Objective: To generate relevant comparative evidence to inform treatment selection for medically inoperable patients or patients who decline surgery with early-stage NSCLC....